PMV Pharmaceuticals Inc’s filing revealed that its 10% Owner ORBIMED ADVISORS LLC unloaded Company’s shares for reported $0.2 million on Nov 22 ’23. In the deal valued at $2.23 per share,87,786 shares were sold. As a result of this transaction, ORBIMED ADVISORS LLC now holds 0 shares worth roughly $0.0.
Then, Alland Leila sold 6,291 shares, generating $41,646 in total proceeds. Upon selling the shares at $6.62, the Chief Medical Officer now owns 45,909 shares.
Before that, Jalota Deepika sold 4,104 shares. PMV Pharmaceuticals Inc shares valued at $27,168 were divested by the Chief Development Officer at a price of $6.62 per share. As a result of the transaction, Jalota Deepika now holds 29,946 shares, worth roughly $46715.76.
Ladenburg Thalmann initiated its PMV Pharmaceuticals Inc [PMVP] rating to a Buy in a research note published on December 27, 2023; the price target was $7. A number of analysts have revised their coverage, including Oppenheimer’s analysts, who increased its forecast for the stock in early March from “a Perform” to “an Outperform”. Goldman also remained covering PMVP and has increased its forecast on September 22, 2021 with a “Buy” recommendation from previously “Neutral” rating. Oppenheimer started covering the stock on August 19, 2021. It rated PMVP as “a Perform”.
Price Performance Review of PMVP
On Monday, PMV Pharmaceuticals Inc [NASDAQ:PMVP] saw its stock fall -2.50% to $1.56. Over the last five days, the stock has lost -12.36%. PMV Pharmaceuticals Inc shares have fallen nearly -49.68% since the year began. Nevertheless, the stocks have fallen -63.64% over the past one year. While a 52-week high of $9.72 was reached on 01/02/24, a 52-week low of $1.17 was recorded on 02/14/24. SMA at 50 days reached $1.7132, while 200 days put it at $3.8277. A total of 0.52 million shares were traded, compared to the trading of 0.58 million shares in the previous session.
Levels Of Support And Resistance For PMVP Stock
The 24-hour chart illustrates a support level at 1.5083, which if violated will result in even more drops to 1.4567. On the upside, there is a resistance level at 1.6133. A further resistance level may holdings at 1.6667. The Relative Strength Index (RSI) on the 14-day chart is 38.84, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.0926, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 84.85%. Stochastics %K at 13.52% indicates the stock is a buying.
How much short interest is there in PMV Pharmaceuticals Inc?
A steep rise in short interest was recorded in PMV Pharmaceuticals Inc stocks on Mar 15, 2024, growing by 0.42 million shares to a total of 2.26 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 1.84 million shares. There was a rise of 18.58%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 5.16% of the overall stock float, the days-to-cover ratio (short ratio) rose to 3.6.
The most recent change occurred on August 02, 2021 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $56 price target.
